Reporting owner · Q3 2026 · CIK 1913253

Guerrero Ramiro: insider trades.

Guerrero Ramiro reported 6 non-derivative transactions on 5 SEC ownership filings in Q3 2026: 6 open-market purchases ($252K) and 0 sales, across 1 company.

Transactions
6
Purchases (P)
6
Sales (S)
0
Companies
1
Name as filed
Guerrero Ramiro

Companies

CompanyRelationshipTransactions
MAIA Biotechnology, Inc. (MAIA)Director6

Transactions

6 non-derivative rows. Shares and prices as filed.
DateCompanyCodeSharesPriceOwned afterFiling
2026-09-10MAIA Biotechnology, Inc.P37,595$1.32773,296Form 4
2026-08-28MAIA Biotechnology, Inc.P46,620$1.35735,701Form 4
2026-08-27MAIA Biotechnology, Inc.P78,239$1.39689,081Form 4
2026-08-26MAIA Biotechnology, Inc.P8,931$1.39610,842Form 4
2026-08-24MAIA Biotechnology, Inc.P1,794$1.33601,911Form 4
2026-08-20MAIA Biotechnology, Inc.P11,899$1.37600,117Form 4

Questions

What stock did Guerrero Ramiro buy or sell?

Guerrero Ramiro reported 6 non-derivative transactions on 5 SEC ownership filings in Q3 2026: 6 open-market purchases ($252K) and 0 sales, across 1 company.

Is Guerrero Ramiro the same person as other filers with this name?

This page covers SEC CIK 1913253 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.

Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.

Plain-text version for agents and LLMs: /insiders/guerrero-ramiro-1913253.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.